We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
-3.32%
1 Year Est. Return
+31.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$262M
AUM Growth
-$10.5M
Cap. Flow
+$1.89M
Cap. Flow %
0.72%
Top 10 Hldgs %
18.95%
Holding
132
New
7
Increased
58
Reduced
39
Closed
13

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$4.91M
2
IONS icon
Ionis Pharmaceuticals
IONS
+$2.51M
3
PAYC icon
Paycom
PAYC
+$2.07M
4
KKR icon
KKR & Co
KKR
+$2.04M
5
UTHR icon
United Therapeutics
UTHR
+$1.83M

Sector Composition

Rank Sector Weight
1 Technology 28.24%
2 Healthcare 23.73%
3 Communication Services 9.87%
4 Financials 9.16%
5 Consumer Discretionary 9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTAS icon
26
Cintas
CTAS
$86.7B
$2.36M 0.9%
35,432
+4,532
+15% +$290K
CPAY icon
27
Corpay
CPAY
$25B
$2.35M 0.9%
8,178
-1,447
-15% -$420K
JJSF icon
28
J&J Snack Foods
JJSF
$1.52B
$2.29M 0.87%
11,965
-739
-6% -$134K
CAKE icon
29
Cheesecake Factory
CAKE
$4.32B
$2.27M 0.87%
55,615
+11,294
+25% +$465K
SNPS icon
30
Synopsys
SNPS
$74.5B
$2.27M 0.87%
16,690
-2,114
-11% -$286K
YELP icon
31
Yelp
YELP
$1.51B
$2.27M 0.86%
65,871
UHS icon
32
Universal Health Services
UHS
$9.72B
$2.26M 0.86%
15,385
+1,495
+11% +$215K
RUN icon
33
Sunrun
RUN
$2.28B
$2.25M 0.86%
139,069
+36,780
+36% +$642K
MEDP icon
34
Medpace
MEDP
$16.3B
$2.23M 0.85%
26,835
-6,845
-20% -$517K
PLD icon
35
Prologis
PLD
$138B
$2.21M 0.84%
25,814
-16,998
-40% -$1.41M
GEO icon
36
The GEO Group
GEO
$4.12B
$2.17M 0.83%
126,392
+50,099
+66% +$898K
STZ icon
37
Constellation Brands
STZ
$22.9B
$2.15M 0.82%
10,424
+3,772
+57% +$757K
SEIC icon
38
SEI Investments
SEIC
$12.3B
$2.13M 0.81%
36,052
+14,498
+67% +$838K
DHR icon
39
Danaher
DHR
$141B
$2.12M 0.81%
16,926
+4,084
+32% +$511K
CSGP icon
40
CoStar Group
CSGP
$12.7B
$2.12M 0.81%
36,710
-10,970
-23% -$657K
FRC
41
DELISTED
First Republic Bank
FRC
$2.12M 0.81%
21,690
+2,345
+12% +$222K
KMI icon
42
Kinder Morgan
KMI
$71.2B
$2.11M 0.8%
102,179
+41,952
+70% +$861K
CARG icon
43
CarGurus
CARG
$3.23B
$2.11M 0.8%
68,973
+13,245
+24% +$451K
KKR icon
44
KKR & Co
KKR
$91.3B
$2.11M 0.8%
+77,215
New +$2.04M
MNST icon
45
Monster Beverage
MNST
$96.5B
$2.1M 0.8%
72,710
+31,272
+75% +$947K
WBA
46
DELISTED
Walgreens Boots Alliance
WBA
$2.1M 0.8%
38,516
+22,129
+135% +$1.19M
IPAR icon
47
Interparfums
IPAR
$4.1B
$2.09M 0.8%
30,743
+3,449
+13% +$229K
SUPN icon
48
Supernus Pharmaceuticals
SUPN
$2.74B
$2.08M 0.79%
75,765
+12,846
+20% +$381K
CCOI icon
49
Cogent Communications
CCOI
$642M
$2.06M 0.78%
37,078
+2,404
+7% +$143K
ALLO icon
50
Allogene Therapeutics
ALLO
$570M
$2.06M 0.78%
75,418
+10,756
+17% +$306K

Similar funds

Capital Impact Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, Capital Impact Advisors held 132 positions worth $262M, down 3.8% from $273M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Capital Impact Advisors's Q3 2019 filing shows 7 new, 58 increased, 39 reduced and 13 closed positions. Its largest new stake was Microsoft: 35,722 shares worth $4.92M. The largest sale was UnitedHealth, an estimated $3.21M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Communication Services.

  • Capital Impact Advisors's largest Q3 2019 buy was Microsoft: 35,722 shares worth $4.92M.
  • Capital Impact Advisors added most to Ionis Pharmaceuticals in Q3 2019, an estimated $2.51M increase.
  • Capital Impact Advisors's biggest Q3 2019 reduction was Alphabet (Google) Class A, cutting an estimated $2.05M.
  • Capital Impact Advisors fully exited UnitedHealth in Q3 2019, selling an estimated $3.21M.
  • Capital Impact Advisors's ten largest holdings make up 19% of its $262M portfolio in Q3 2019.
  • Capital Impact Advisors opened 7 new positions and closed 13 in Q3 2019.
  • Capital Impact Advisors's portfolio value fell 3.8% quarter-over-quarter to $262M.

Based on Capital Impact Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.